Literature DB >> 31285956

How to train a mouse-methodological issues in pre-clinical exercise oncology.

Luma Melo1,2, Amit Hagar1,3,2.   

Abstract

We point at several challenges that current exercise oncology rodent models face, which call their human-relevance into question: the vast majority of pre-clinical studies in exercise oncology treat "physical exercise" as a primitive concept without further analysis or qualification, and their results are based on dosages that no human can endure. The lack of analysis and qualification together with the dosage mismatch conceal the fact that rodents do not run like humans. Consequently, while these pre-clinical studies may yield insights into potential biological mechanisms underlying the systemic effects of physical exercise on cancer, the applicability of this knowledge to preventive interventions in healthy humans and the ability to translate it to practical therapies in the critically ill remain limited. We propose an alternative exercise rodent model that has better chances of meeting these challenges.

Entities:  

Keywords:  Exercise oncology; dose-response; human relevance; rodent models; translational research

Year:  2019        PMID: 31285956      PMCID: PMC6610064     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  5 in total

1.  Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy.

Authors:  Josua Aponte Serrano; Amit Hagar
Journal:  Cancer Immunol Immunother       Date:  2021-01-08       Impact factor: 6.968

2.  Ethical consideration and feasibility demonstration of high-intensity interval training without the use of electrical shocks in mice with and without doxorubicin exposition.

Authors:  Maxime Caru; François Lalonde; Elise Legault; Daniel Curnier; David H St-Pierre; Alain Steve Comtois; François Tournoux
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

3.  Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model.

Authors:  Xue-Feng Liu; Xiao-Dong Zhu; Long-Hai Feng; Xiao-Long Li; Bin Xu; Kang-Shuai Li; Nan Xiao; Ming Lei; Hui-Chuan Sun; Zhao-You Tang
Journal:  Exp Hematol Oncol       Date:  2022-04-04

4.  Exercise protocols: The gap between preclinical and clinical exercise oncology studies.

Authors:  Mahmoud Delphan; Neda Delfan; Daniel West; Maryam Delfan
Journal:  Metabol Open       Date:  2022-01-22

5.  The effect of endurance training on non-alcoholic fatty liver disease in mice.

Authors:  Luma Melo; Merve Bilici; Amit Hagar; James E Klaunig
Journal:  Physiol Rep       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.